Wockhardt Ltd

The United Kingdom has extended a deal with Wockhardt Ltd for the supply of COVID-19 vaccines by six months, the drugmaker said on Wednesday.

Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.

Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.

Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.

Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth.

Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.

The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.

Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).

Pharmaceuticals major WockhardtLtd on Thursday reported an 82.44 per cent decline in consolidatednet profit at Rs 60.97 crore for the fiscal third quarter that ended onDecember 31, 2015.

Drug maker Wockhardt Ltd said the US Food and Drug Administration (FDA) had issued a notice outlining manufacturing violations at its Shendra plant in western India, delaying the company's plans to rebuild its battered US business.

According to the Enforcement Report for the week of June 24, 2015, the US health regulator has said 86,106 cartons of over-the-counter (OTC) Famotidine tablets USP of 20 mg are being voluntarily recalled by Allegiant Health.

Generic drug maker Wockhardt Ltd on Tuesday said it would recall some drugs manufactured at its two plants in India before the US Food and Drug Administration (FDA) banned those sites due to quality concerns.

Drug maker Wockhardt Ltd on Wednesday said the US Food and Drug Administration (FDA) has not found any issues with respect to data security and control measures at Chikalthana plant in a recent inspection, but suggested continuous voluntary compliance for "desired quality culture".

Shares in Wockhardt Ltd fell as much as 5.3 per cent on Thursday after the drug maker said the US Food and Drug Administration (FDA) had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.

Ipca had voluntarily halted shipments to the United States from the plant in July last year after the FDA outlined half a dozen violations including data integrity issues.

The United Kingdom has extended a deal with Wockhardt Ltd for the supply of COVID-19 vaccines by six months, the drugmaker said on Wednesday.

Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.

Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.

Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.

Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth.

Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.

The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.

Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).

Pharmaceuticals major WockhardtLtd on Thursday reported an 82.44 per cent decline in consolidatednet profit at Rs 60.97 crore for the fiscal third quarter that ended onDecember 31, 2015.

Drug maker Wockhardt Ltd said the US Food and Drug Administration (FDA) had issued a notice outlining manufacturing violations at its Shendra plant in western India, delaying the company's plans to rebuild its battered US business.

According to the Enforcement Report for the week of June 24, 2015, the US health regulator has said 86,106 cartons of over-the-counter (OTC) Famotidine tablets USP of 20 mg are being voluntarily recalled by Allegiant Health.

Generic drug maker Wockhardt Ltd on Tuesday said it would recall some drugs manufactured at its two plants in India before the US Food and Drug Administration (FDA) banned those sites due to quality concerns.

Drug maker Wockhardt Ltd on Wednesday said the US Food and Drug Administration (FDA) has not found any issues with respect to data security and control measures at Chikalthana plant in a recent inspection, but suggested continuous voluntary compliance for "desired quality culture".

Shares in Wockhardt Ltd fell as much as 5.3 per cent on Thursday after the drug maker said the US Food and Drug Administration (FDA) had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.

Ipca had voluntarily halted shipments to the United States from the plant in July last year after the FDA outlined half a dozen violations including data integrity issues.